These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 20601829)

  • 1. Concurrent chemoradiotherapy with S-1 for T2N0 glottic squamous cell carcinoma.
    Nonoshita T; Shioyama Y; Nakamura K; Nakashima T; Ohga S; Yoshitake T; Ohnishi K; Terashima K; Asai K; Honda H
    J Radiat Res; 2010; 51(4):481-4. PubMed ID: 20601829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical evaluation of a prospective study of concurrent chemoradiotherapy with S-1 for early glottic carcinoma.
    Kimura K; Itoh Y; Okada T; Nakahara R; Kawamura M; Kubota S; Itoh J; Hiramatsu M; Fujimoto Y; Shibata T; Naganawa S
    Anticancer Res; 2015 Apr; 35(4):2385-90. PubMed ID: 25862904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Concurrent chemoradiotherapy with S-1 for T2N0 glottic carcinoma].
    Ikeda Y; Tsukuda M; Tanigaki Y; Yabuki K; Mitake D; Ishitoya J
    Gan To Kagaku Ryoho; 2008 May; 35(5):789-92. PubMed ID: 18487914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective analysis: concurrent chemoradiotherapy and adjuvant chemotherapy for T2N0 glottic squamous cell carcinoma.
    Nonoshita T; Shioyama Y; Kunitake N; Nakamura K; Nomoto S; Ohga S; Toriya Y; Ono M; Honda H
    Fukuoka Igaku Zasshi; 2009 Jan; 100(1):26-31. PubMed ID: 19378773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiotherapy concurrent with S-1 and radiotherapy alone for T2N0 glottic carcinoma: a retrospective comparative study.
    Higashino M; Kawata R; Lee K; Nishikawa S; Ichihara S; Uesugi Y
    Auris Nasus Larynx; 2014 Aug; 41(4):364-8. PubMed ID: 24656970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase I study of concurrent chemoradiotherapy with S-1 for T2N0 glottic carcinoma.
    Tsuji H; Kiba T; Nagata M; Inoue T; Yukawa H; Yamashita T; Shimode Y; Murata H; Nagata K; Tomoda K
    Oncology; 2006; 71(5-6):369-73. PubMed ID: 17851262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical phase I trial of concurrent chemo-radiotherapy with S-1 for T2NO glottic carcinoma].
    Tsuji H; Nagata M; Inoue T; Minami T; Iwai H; Ohnishi S; Yukawa H; Ogura M; Yamashita T; Nagata K
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():163-6. PubMed ID: 16897995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study Protocol: Prospective Study of Concurrent Chemoradiotherapy with S-1 and Hypofractionated Radiotherapy for Outpatients with Early Glottic Squamous Cell Carcinomas.
    Kimura K; Itoh Y; Okada T; Kubota S; Kawamura M; Nakahara R; Oie Y; Kozai Y; Takase Y; Tsuzuki H; Nishio N; Hiramatsu M; Fujimoto Y; Mizutani T; Hirakawa A; Naganawa S
    Asian Pac J Cancer Prev; 2018 May; 19(5):1195-1199. PubMed ID: 29801401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent chemoradiotherapy with carboplatin and uracil-ftegafur in patients with stage two (T2 N0 M0) squamous cell carcinoma of the glottic larynx.
    Taguchi T; Tsukuda M; Mikami Y; Horiuchi C; Ishitoya JI; Katori H
    J Laryngol Otol; 2006 Jun; 120(6):478-81. PubMed ID: 16563197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of S-1 (tegafur, gimeracil, and oteracil potassium) concurrent with 3-dimensional conformal radiotherapy for newly diagnosed squamous cell carcinoma of the lung in elderly patients.
    Wang T; Zhang SF; Qiu MQ; Li QL
    Cancer Radiother; 2016 May; 20(3):181-6. PubMed ID: 27068497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I/II trial of concurrent use of S-1 and radiation therapy for T2 glottic cancer.
    Nakayama M; Hayakawa K; Okamoto M; Niibe Y; Ishiyama H; Kotani S
    Jpn J Clin Oncol; 2010 Oct; 40(10):921-6. PubMed ID: 20495190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and feasibility of ambulatory treatment-based monthly nedaplatin plus S-1 in definitive or salvage concurrent chemoradiotherapy for early, advanced, and relapsed esophageal cancer.
    Yamashita H; Haga A; Takenaka R; Kiritoshi T; Okuma K; Ohtomo K; Nakagawa K
    Radiat Oncol; 2016 Jan; 11():4. PubMed ID: 26781439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent chemoradiotherapy with conventional fractionated radiotherapy and low-dose daily cisplatin plus weekly docetaxel for T2N0 glottic cancer.
    Saitoh JI; Shirai K; Imaeda M; Musha A; Abe T; Shino M; Takayasu Y; Takahashi K; Chikamatsu K; Nakano T
    Radiat Oncol; 2017 Feb; 12(1):39. PubMed ID: 28219396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of combined modality treatment with radiotherapy and S-1 on T2N0 laryngeal cancer: Possible improvement in survival through the prevention of second primary cancer and distant metastasis.
    Kitani Y; Kubota A; Furukawa M; Hori Y; Nakayama Y; Nonaka T; Mizoguchi N; Kitani Y; Hatakeyama H; Oridate N
    Oral Oncol; 2017 Aug; 71():54-59. PubMed ID: 28688691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early glottic cancer treatment with concurrent chemoradiotherapy with once-daily orally administered S-1.
    Takase Y; Itoh Y; Ohtakara K; Kawamura M; Ito J; Oie Y; Ono T; Sasaki Y; Nishida A; Naganawa S
    Nagoya J Med Sci; 2021 May; 83(2):251-258. PubMed ID: 34239173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of concurrent chemoradiotherapy with S-1 in patients with stage II (T2N0M0) squamous cell carcinoma of the Pharynx or Larynx.
    Taguchi T; Takahashi M; Nishimura G; Shiono O; Komatsu M; Sano D; Sakuma Y; Tanigaki Y; Kubota A; Taguri M; Hata M; Oridate N
    Jpn J Clin Oncol; 2014 Dec; 44(12):1158-63. PubMed ID: 25267992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I/II trial of chemoradiotherapy with concurrent S-1 and cisplatin for clinical stage II/III esophageal carcinoma (JCOG 0604).
    Tahara M; Fuse N; Mizusawa J; Sato A; Nihei K; Kanato K; Kato K; Yamazaki K; Muro K; Takaishi H; Boku N; Ohtsu A
    Cancer Sci; 2015 Oct; 106(10):1414-20. PubMed ID: 26250827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of concomitant therapy with S-1, CDGP, and radiation for laryngeal cancer].
    Morimoto M; Takemura H; Yui T; Suzuki T; Sanbe T; Suzaki H
    Gan To Kagaku Ryoho; 2010 Oct; 37(10):1903-6. PubMed ID: 20948253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I trial of chemoradiotherapy with the combination of S-1 plus cisplatin for patients with unresectable locally advanced squamous cell carcinoma of the head and neck.
    Tahara M; Minami H; Kawashima M; Kawada K; Mukai H; Sakuraba M; Matsuura K; Ogino T; Hayashi R; Ohtsu A
    Cancer Sci; 2011 Feb; 102(2):419-24. PubMed ID: 21134076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term efficacy and toxicity of concurrent chemoradiotherapy with nedaplatin and S-1 for head and neck squamous cell carcinoma.
    Okuda H; Ohnishi M; Takahashi H; Takagi C; Takada N; Ohashi T
    Auris Nasus Larynx; 2019 Dec; 46(6):882-888. PubMed ID: 31176493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.